Mild induced hypothermia and coagulation and platelet function in patients with septic shock: Secondary outcome of a randomized trial

被引:4
作者
Itenov, Theis S. [1 ,2 ,3 ,12 ]
Kromann, Maria E. [1 ]
Ostrowski, Sisse R. [3 ,4 ]
Bestle, Morten H. [3 ,5 ,6 ]
Mohr, Thomas [6 ]
Gyldensted, Louise
Lindhardt, Anne [5 ]
Thormar, Katrin [2 ]
Sessler, Daniel I. [7 ]
Juffermans, Nicole P. [8 ,9 ]
Lundgren, Jens D. [1 ,3 ]
Jensen, Jens-Ulrik [1 ,3 ,10 ,11 ]
机构
[1] Copenhagen Univ Hosp, Dept Infect Dis, CHIPPERSIMUNE, Rigshosp, Copenhagen, Denmark
[2] Copenhagen Univ Hosp Bispebjerg, Dept Anesthesiol, Copenhagen, Denmark
[3] Univ Copenhagen, Fac Hlth Sci, Dept Clin Med, Copenhagen, Denmark
[4] Rigshosp, Copenhagen Univ Hosp, Dept Clin Immunol, Copenhagen, Denmark
[5] Copenhagen Univ Hosp North Zealand, Dept Anesthesia & Intens Care, Copenhagen, Denmark
[6] Copenhagen Univ Hosp Herlev Gentofte, Dept Anesthesiol, Copenhagen, Denmark
[7] Cleveland Clin, Anesthesiol Inst, Dept Outcomes Res, Cleveland, OH USA
[8] OLVG Hosp, Dept Intens Care, Amsterdam, Netherlands
[9] Amsterdam Univ Med Ctr, Lab Expt Intens Care & Anesthesiol, Amsterdam, Netherlands
[10] Copenhagen Univ Hosp Gentofte, Dept Internal Med, Resp Sect, Copenhagen, Denmark
[11] Outcomes Res Consortium, Cleveland, OH USA
[12] Bispebjerg Hosp, Dept Anesthesiol & Crit Care, Bispebjerg Bakke 23, DK-2400 Copenhagen, Capital Region, Denmark
基金
新加坡国家研究基金会;
关键词
coagulopathy; sepsis; septic shock; therapeutic hypothermia; TARGETED TEMPERATURE MANAGEMENT; CARDIAC-ARREST; BLOOD-COAGULATION; COAGULOPATHY; INFLAMMATION; SURVIVAL; ACIDOSIS; SEPSIS; THROMBOELASTOMETRY; HEMOSTASIS;
D O I
10.1111/aas.14254
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Coagulation abnormalities and microthrombi contribute to septic shock, but the impact of body temperature regulation on coagulation in patients with sepsis is unknown. We tested the hypothesis that mild induced hypothermia reduces coagulation and platelet aggregation in patients with septic shock. Secondary analysis of randomized controlled trial. Adult patients with septic shock who required mechanical ventilation from eight intensive care units in Denmark were randomly assigned to mild induced hypothermia for 24 h or routine thermal management. Viscoelastography and platelet aggregation were assessed at trial inclusion, after 12 h of thermal management, and 24 h after inclusion. A total of 326 patients were randomized to mild induced hypothermia (n = 163) or routine thermal management (n = 163). Mild induced hypothermia slightly prolonged activated partial thromboplastin time and thrombus initiation time (R time 8.0 min [interquartile range, IQR 6.6-11.1] vs. 7.2 min [IQR 5.8-9.2]; p =.004) and marginally inhibited thrombus propagation (angle 68 degrees [IQR 59-73] vs. 71 degrees [IQR 63-75]; p =.014). The effect was also present after 24 h. Clot strength remained unaffected (MA 71 mm [IQR 66-76] with mild induced hypothermia vs. 72 mm (65-77) with routine thermal management, p =.9). The proportion of patients with hyperfibrinolysis was not affected (0.7% vs. 3.3%; p =.19), but the proportion of patients with no fibrinolysis was high in the mild hypothermia group (8.8% vs. 40.4%; p <.001). The mild induced hypothermia group had lower platelet aggregation: ASPI 85U (IQR 50-113) versus 109U (IQR 74-148, p <.001), ADP 61U (IQR 40-83) versus 79 U (IQR 54-101, p <.001), TRAP 108 (IQR 83-154) versus 119 (IQR 94-146, p =.042) and COL 50U (IQR 34-66) versus 67U (IQR 46-92, p <.001). In patients with septic shock, mild induced hypothermia slightly impaired clot initiation, but did not change clot strength. Platelet aggregation was slightly impaired. The effect of mild induced hypothermia on viscoelastography and platelet aggregation was however not in a range that would have clinical implications. We did observe a substantial reduction in fibrinolysis.
引用
收藏
页码:909 / 917
页数:9
相关论文
共 50 条
  • [31] Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial
    Lyu, Qing-Quan
    Zheng, Rui-Qiang
    Chen, Qi-Hong
    Yu, Jiang-Quan
    Shao, Jun
    Gu, Xiao-Hua
    CRITICAL CARE, 2022, 26 (01)
  • [32] A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock
    Alía, I
    Esteban, A
    Gordo, F
    Lorente, JA
    Diaz, C
    Rodriguez, JA
    Frutos, F
    CHEST, 1999, 115 (02) : 453 - 461
  • [33] A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock
    Choudhury, Ashok
    Kedarisetty, Chandan K.
    Vashishtha, Chitranshu
    Saini, Deepak
    Kumar, Sachin
    Maiwall, Rakhi
    Sharma, Manoj K.
    Bhadoria, Ajeet S.
    Kumar, Guresh
    Joshi, Yogendra K.
    Sarin, Shiv K.
    LIVER INTERNATIONAL, 2017, 37 (04) : 552 - 561
  • [34] Early alterations in platelet mitochondrial function are associated with survival and organ failure in patients with septic shock
    Puskarich, Michael A.
    Kline, Jeffrey A.
    Watts, John A.
    Shirey, Kristin
    Hosler, Jonathan
    Jones, Alan E.
    JOURNAL OF CRITICAL CARE, 2016, 31 (01) : 63 - 67
  • [35] The outcome of IV vitamin C therapy in patients with sepsis or septic shock: a meta-analysis of randomized controlled trials
    Baofang Liang
    Jianwei Su
    Hanquan Shao
    Huiying Chen
    Baocheng Xie
    Critical Care, 27
  • [36] The outcome of IV vitamin C therapy in patients with sepsis or septic shock: a meta-analysis of randomized controlled trials
    Liang, Baofang
    Su, Jianwei
    Shao, Hanquan
    Chen, Huiying
    Xie, Baocheng
    CRITICAL CARE, 2023, 27 (01)
  • [37] Acetylsalicylic Acid Treatment in Patients With Sepsis and Septic Shock: A Phase 2, Placebo-Controlled, Randomized Clinical Trial
    Almeida, Thiago M. L.
    Freitas, Flavio G. R.
    Figueiredo, Rodrigo C.
    Houly, Sandra G.
    Azevedo, Luciano C. P.
    Cavalcanti, Alexandre B.
    Damiani, Lucas P.
    Svicero, Bianca S.
    Souza, Maria A.
    Bustamante, Cintia L. S.
    Ramos, Fernando J. S.
    Alves, Rafael S. V.
    Atallah, Fernanda C.
    Jackiu, Miriam
    Pacheco, Eduardo S.
    Schmidt, Raysa C.
    Serra, Felipe S. C.
    Tomotani, Daniere Y. V.
    Zampieri, Fernando G.
    Machado, Flavia R.
    BRICNET
    CRITICAL CARE MEDICINE, 2025, 53 (02) : e269 - e281
  • [38] Dextrose 5% versus normal saline as maintenance fluid therapy in patients with septic shock (DEMANDS): a randomized controlled trial
    Fayed, Akram Muhammad
    Osman, Mohamed Osman Elsayed
    Megahed, Mohammed Mostafa
    Abdelhady, Mohamed Abdelalim
    Saleh, Ahmad Sabry
    ALEXANDRIA JOURNAL OF MEDICINE, 2024, 60 (01) : 192 - 199
  • [39] Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial
    Miguel Ibarra-Estrada
    Eduardo Kattan
    Pavel Aguilera-González
    Laura Sandoval-Plascencia
    Uriel Rico-Jauregui
    Carlos A. Gómez-Partida
    Iris X. Ortiz-Macías
    José A. López-Pulgarín
    Quetzalcóatl Chávez-Peña
    Julio C. Mijangos-Méndez
    Guadalupe Aguirre-Avalos
    Glenn Hernández
    Critical Care, 27
  • [40] Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial
    Martin Unger
    Andrea Morelli
    Mervyn Singer
    Peter Radermacher
    Sebastian Rehberg
    Helmut Trimmel
    Michael Joannidis
    Gottfried Heinz
    Vladimír Cerny
    Pavel Dostál
    Christian Siebers
    Fabio Guarracino
    Francesca Pratesi
    Gianni Biancofiore
    Massimo Girardis
    Pavla Kadlecova
    Olivier Bouvet
    Michael Zörer
    Barbara Grohmann-Izay
    Kurt Krejcy
    Christoph Klade
    Günther Krumpl
    Trials, 19